Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05931406
Other study ID # RBHP 2022 DUTHEIL
Secondary ID 2022-A02730-43
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 2024
Est. completion date September 2026

Study information

Verified date June 2023
Source University Hospital, Clermont-Ferrand
Contact Lise LACLAUTRE
Phone 334.73.754.963
Email promo_interne_drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to study changes in sedentary behavior following a behavioral intervention (sit-and-stand desk, and cycloergometer)


Description:

Each emergency medical services dispatcher and each firefighter participates in the study for three days. A normal working day from of 12h is compared to: (i) a working day during which the participants have to get up at least 5 min/hour (sit-and-stand desk), (ii) a working day during which they can use a cycloergometer installed under the desk. Conditions will be random using Latin Square design with stratification between sequences cross-over design on occupation (EMD vs. firefighters). The heart rate variability (measured using Zephyr®), the electrodermal activity (Empatica® E4), the level of physical activity (Actigraph®) as well as the blood sugar (Freestyle®) will be measured continuously during the 12 hours of work and the night after except for Actigraph® and Freestyle® device that will be let one week. Blood and saliva samples will be collected on each working day, at the beginning and end of the day i.e. two measures for blood samples, and every three hours i.e. 5 measures for saliva sampling. Participants will have to complete a detailed questionnaire to identify the particular events (vital emergencies, etc.) that may influence the parameters measured. Participants will be asked to answer a general questionnaire once at the start of the study that will cover different aspects: - Sociodemographic, - Visual analogue scale (VAS) related to psychosocial factors : stress at home, burnout / burnout, decision latitude / autonomy at work, psychological demands at work (workload), support from the hierarchy, support from co-workers, family support, job satisfaction with regard to effort, commitment to work, addiction to work, quality of life, need for psychological support, - Eating habits. They will then have to answer a short questionnaire at the beginning and at the end of each measurement day. It will cover different aspects: - Four VAS (stress level, fatigue, anxiety, mood), - Physical activity and sedentary lifestyle (number of hours of physical activity and sitting during the last 24 hours), - Daily consumption (tobacco, alcohol, cannabis, coffee, tea).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 36
Est. completion date September 2026
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Emergency medical dispatchers or firefighters from the departmental fire and rescue operational center (CODIS). - Person able to give an informed consent to participate in research - Affiliated with a Social Security scheme. - Being able to use the sit-stand desk and the cycle ergometer Exclusion Criteria: - Non-affiliated to a health insurance, - Protected persons (minors, pregnant women, breastfeeding women, guardianship, curatorship, deprived of freedoms, safeguard of justice), - Refusal to participate.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Control
A normal working day from of 12h
Sit-and-stand desk
a working day during which the participants have to get up at least 5 min/hour
Cycloergometer
a working day during which they can use a cycloergometer installed under the desk

Locations

Country Name City State
France CHU clermont-ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sedentary behavior Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active. 12 hours of work corresponding to the control condition
Primary Sedentary behavior Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active. 12 hours of work corresponding to the sit-and-stand desk condition
Primary Sedentary behavior Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active. 12 hours of work corresponding to the cycloergometer condition
Secondary Sedentary behavior Sedentary behavior measured by actimetry using Actigraph® in number of minutes standing/active during one week. one-week (168 hours) sit-and-stand desk cycle
Secondary Sedentary behavior Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active. one-week (168 hours) control cycle
Secondary Sedentary behavior Sedentary behavior measured by actimetry using Actigraph® in number of minutes standing/active during one week. one-week (168 hours) cycloergometer cycle
Secondary Heart rate variability The heart rate variability measured using Zephyr® 24 hours record corresponding to 12 hours of work and the next 12 hours of rest
Secondary Electrodermal activity The electrodermal activity measured using Empatica E4 24 hours record corresponding to 12 hours of work and the next 12 hours of rest
Secondary Stress at home Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the control day
Secondary Stress at home Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the sit-and-stand desk day
Secondary Stress at home Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the cycloergometer day
Secondary Stress at home Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the control day
Secondary Stress at home Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the sit-and-stand desk day
Secondary Stress at home Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the cycloergometer day
Secondary Fatigue Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the control day
Secondary Fatigue Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the sit-and-stand desk day
Secondary Fatigue Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the cycloergometer day
Secondary Fatigue Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the control day
Secondary Fatigue Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the sit-and-stand desk day
Secondary Fatigue Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the cycloergometer day
Secondary Anxiety Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the control day
Secondary Anxiety Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the sit-and-stand desk day
Secondary Anxiety Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 am, beginning of the cycloergometer day
Secondary Anxiety Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the control day
Secondary Anxiety Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the sit-and-stand desk day
Secondary Anxiety Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. 6 pm, end of the cycloergometer day
Secondary Mood Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent). Higher scores mean a better outcome. 6 pm, beginning of the control day
Secondary Mood Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome. 6 am, beginning of the sit-and-stand desk day
Secondary Mood Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome. 6 am, beginning of the cycloergometer day
Secondary Mood Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome. 6 pm, end of the control day
Secondary Mood Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome. 6 pm, end of the sit-and-stand desk day
Secondary Mood Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome. 6 pm, end of the cycloergometer day
Secondary Stress at work Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome. 6 am, beginning of the control day
Secondary Stress at work Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome. 6 am, beginning of the sit-and-stand desk day
Secondary Stress at work Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome. 6 am, beginning of the cycloergometer desk day
Secondary Stress at work Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome. 6 pm, end of the control day
Secondary Stress at work Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome. 6 pm, end of the sit-and-stand desk day
Secondary Stress at work Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome. 6 pm, end of the cycloergometer day
Secondary Amount of physical activity Number of hours of physical activity during the last 24 hours 6 am, beginning of the control day
Secondary Intensity of physical activity Physical activity intensity during the last 24 hours measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity. 6 am, beginning of the control day
Secondary Amount of physical activity Number of hours of physical activity during the last 24 hours 6 am, beginning of the sit-and-stand desk day
Secondary Intensity of physical activity Physical activity intensity during the last 24 hours measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity. 6 am, beginning of the sit-and-stand desk day
Secondary Amount of physical activity Number of hours of physical activity during the last 24 hours 6 am, beginning of the cycloergometer day
Secondary Intensity of physical activity Physical activity intensity during the last 24 hours measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity. 6 am, beginning of the cycloergometer day
Secondary Amount of physical activity Number of hours of physical activity during the working day 6 pm, end of the control day
Secondary Intensity of physical activity Physical activity intensity during the working day measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity. 6 pm, end of the control day
Secondary Amount of physical activity Number of hours of physical activity during the working day 6 pm, end of the sit-and-stand desk day
Secondary Intensity of physical activity Physical activity intensity during the working day measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity. 6 pm, end of the sit-and-stand desk day
Secondary Amount of physical activity Number of hours of physical activity during the working day 6 pm, end of the cycloergometer day
Secondary Intensity of physical activity Physical activity intensity during the working day measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity. 6 pm, end of the cycloergometer day
Secondary Sitting time Number of hours sit during the last 24 hours 6 am, beginning of the control day
Secondary Sitting time Number of hours sit during the last 24 hours 6 am, beginning of the sit-and-stand desk day
Secondary Sitting time Number of hours sit during the last 24 hours 6 am, beginning of the cycloergometer day
Secondary Sitting time Number of hours sit during the working day 6 pm, end of the control day
Secondary Sitting time Number of hours sit during the working day 6 pm, end of the sit-and-stand desk day
Secondary Sitting time Number of hours sit during the working day 6 pm, end of the cycloergometer day
Secondary Tabacco consumption Number of cigarette during the last 24h 6 am, beginning of the control day
Secondary Tabacco consumption Number of cigarette during the last 24h 6 am, beginning of the sit-and-stand desk day
Secondary Tabacco consumption Number of cigarette during the last 24h 6 am, beginning of the cycloergometer day
Secondary Tabacco consumption Number of cigarette during the working day 6 pm, end of the control day
Secondary Tabacco consumption Number of cigarette during the working day 6 pm, end of the sit-and-stand desk day
Secondary Tabacco consumption Number of cigarette during the working day 6 pm, end of the cycloergometer day
Secondary Tea consumption Number of cups of tea during the last 24h 6 am, beginning of the control day
Secondary Tea consumption Number of cups of tea during the last 24h 6 am, beginning of the sit-and-stand desk day
Secondary Tea consumption Number of cups of tea during the last 24h 6 am, beginning of the cycloergometer day
Secondary Tea consumption Number of cups of tea during the last 24h 6 pm, end of the control day
Secondary Tea consumption Number of cups of tea during the last 24h 6 pm, end of the sit-and-stand desk day
Secondary Tea consumption Number of cups of tea during the last 24h 6 pm, end of the cycloergometer day
Secondary Coffee consumption Number of cups of coffee during the last 24h 6 am, beginning of the control day
Secondary Coffee consumption Number of cups of coffee during the last 24h 6 am, beginning of the sit-and-stand desk day
Secondary Coffee consumption Number of cups of coffee during the last 24h 6 am, beginning of the cycloergometer day
Secondary Coffee consumption Number of cups of coffee during the working day 6 pm, end of the control day
Secondary Coffee consumption Number of cups of coffee during the working day 6 pm, end of the sit-and-stand desk day
Secondary Coffee consumption Number of cups of coffee during the working day 6 pm, end of the cycloergometer day
Secondary Sociodemographic Sociodemographic will be assessed: gender, age, marital status, children, occupation, and recent stressful event Once at baseline
Secondary Sleep quality Sleep quality measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent). Higher scores mean a better outcome. Once at baseline
Secondary Family support Family support measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome. Once at baseline
Secondary Burnout Burnout measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. Once at baseline
Secondary Job demand Job demand measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome. Once at baseline
Secondary Job control Job control measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome. Once at baseline
Secondary Hierarchy support Hierarchy support measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome. Once at baseline
Secondary Colleagues support Colleagues support measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome. Once at baseline
Secondary Effort reward-imbalance Effort reward-imbalance measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome. Once at baseline
Secondary Medical treatment Medical treatment measured using multi-choice question "do you take long term medication?" Once at baseline
Secondary Allergy Allergy measured using multi-choice question "do you have allergy?" Once at baseline
Secondary Average physical activity Average number of hours of physical activity per week Once at baseline
Secondary Average physical activity intensity Average physical activity intensity per week Once at baseline
Secondary Average tabacco consumption Average number of cigarette per day Once at baseline
Secondary Average alcohol consumption Average number of alcohol glasses per week Once at baseline
Secondary Average cannabis consumption Average number of cannabis joint per week Once at baseline
Secondary Average tea consumption Average number of cup of tea per day Once at baseline
Secondary Average coffee consumption Average number of cup of coffee per day Once at baseline
Secondary Average food consumption Average food consumption of 16 food groups Once at baseline
Secondary Diet characterization "How do you characterize your diet" measured on a visual analogue scale ranging from 0 (Not at all balanced) to 100 (Very balanced) Once at baseline
Secondary RPAQ questionnaire The Recent Physical Activity Questionnaire (RPAQ) assesses the level of physical activity and sedentary lifestyle in adults over the past four weeks. It is divided into three parts: work and study, home and leisure, and finally, stairs and travel. It makes it possible to classify individuals into several categories, one on sedentary lifestyle (low, resistant either 3-7h/day or high or >7h/day) and one on the level of physical activity (<8.3 Metabolic equivalent of task(MET).hour/week: inactive or >8.3 MET.h/wk: active). Once at baseline
Secondary MBI questionnaire The Maslach Burn-out Inventory (MBI) is composed of 22 items designed to assess the three components of the burn-out syndrome: emotional exhaustion (9 items), depersonalization (5 items) and reduced personal accomplishment (8 items). The items are written in the form of statements about personal feelings or attitudes. Items are made of a 7-point scale frequency of feelings, varying from "never" to "every day". The scores for each component of the burn-out syndrome are considered separately. If desired for participant feedback, each score can be coded as low, average, or high. Once at baseline
Secondary JDCS questionnaire The Job Demand-Control-Support (JDCS) questionnaire of Karasek assess job demands, job control and social support through 26 items. The questionnaire measures nine items of job demands, nine items of job control and eight items of social support. Items of JDCS are scored on a four-point Likert-type scale, ranging from 1 = strongly disagree to 4 = strongly agree. Among the 26 items, five negative statements require reverse scoring. From French data, the job strain threshold is set for a demands score higher than 20 and a control score lower than 71; the isostrain threshold is determined from a combining score of job strain and social support lower than 24. We would ask the participants to fulfil the questionnaire from memories that they keep of their work. Once at baseline
Secondary ERI questionnaire The Effort-Reward Imbalance Questionnaire (ERI) is a self-administrated test assessing psychological distress and health problems that may occur when there is an imbalance between the efforts required by the work and the rewards received. We used the 46 items of the French version of the ERI model exploring efforts (six items), over commitment (eleven items), and rewards (seventeen items). Items of ERI were scored on a five-point Likert-type scale, ranging from 1 = disagree to 5 = agree and very disturbed. A ratio extrinsic efforts and rewards can assess the imbalance between these two dimensions. A ratio greater than one defines employees exposed to an imbalance between efforts and rewards. Once at baseline
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 6 am, beginning of the control day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 6 am, beginning of the control day
Secondary Salivary leptin Salivary leptin measured in ng/ml 6 am, beginning of the control day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 6 am, beginning of the control day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 9 am on the control day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 9 am on the control day
Secondary Salivary leptin Salivary leptin measured in ng/ml 9 am on the control day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 9 am on the control day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 12 am on the control day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 12 am on the control day
Secondary Salivary leptin Salivary leptin measured in ng/ml 12 am on the control day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 12 am on the control day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 3 pm on the control day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 3 pm on the control day
Secondary Salivary leptin Salivary leptin measured in ng/ml 3 pm on the control day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 3 pm on the control day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 6 pm, end of the control day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 6 pm, end of the control day
Secondary Salivary leptin Salivary leptin measured in ng/ml 6 pm, end of the control day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 6 pm, end of the control day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 6 am, beginning of the sit-and-stand desk day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 6 am, beginning of the sit-and-stand desk day
Secondary Salivary leptin Salivary leptin measured in ng/ml 6 am, beginning of the sit-and-stand desk day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 6 am, beginning of the sit-and-stand desk day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 9 am on the sit-and-stand desk day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 9 am on the sit-and-stand desk day
Secondary Salivary leptin Salivary leptin measured in ng/ml 9 am on the sit-and-stand desk day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 9 am on the sit-and-stand desk day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 12 am on the sit-and-stand desk day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 12 am on the sit-and-stand desk day
Secondary Salivary leptin Salivary leptin measured in ng/ml 12 am on the sit-and-stand desk day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 12 am on the sit-and-stand desk day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 3 pm on the sit-and-stand desk day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 3 pm on the sit-and-stand desk day
Secondary Salivary leptin Salivary leptin measured in ng/ml 3 pm on the sit-and-stand desk day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 3 pm on the sit-and-stand desk day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 6 pm, end of the sit-and-stand desk day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 6 pm, end of the sit-and-stand desk day
Secondary Salivary leptin Salivary leptin measured in ng/ml 6 pm, end of the sit-and-stand desk day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 6 pm, end of the sit-and-stand desk day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 6 am, beginning of the cycloergometer day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 6 am, beginning of the cycloergometer day
Secondary Salivary leptin Salivary leptin measured in ng/ml 6 am, beginning of the cycloergometer day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 6 am, beginning of the cycloergometer day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 9 am on the cycloergometer day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 9 am on the cycloergometer day
Secondary Salivary leptin Salivary leptin measured in ng/dml 9 am on the cycloergometer day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 9 am on the cycloergometer day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 12 am on the cycloergometer day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 12 am on the cycloergometer day
Secondary Salivary leptin Salivary leptin measured in ng/ml 12 am on the cycloergometer day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 12 am on the cycloergometer day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 3 pm on the cycloergometer day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 3 pm on the cycloergometer day
Secondary Salivary leptin Salivary leptin measured in ng/ml 3 pm on the cycloergometer day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 3 pm on the cycloergometer day
Secondary Salivary cortisol Salivary cortisol measured in µg/dl 6 pm, end of the cycloergometer day
Secondary Salivary DHEAS Salivary DHEAS measured in pg/ml 6 pm, end of the cycloergometer day
Secondary Salivary leptin Salivary leptin measured in ng/ml 6 pm, end of the cycloergometer day
Secondary Salivary ghrelin Salivary ghrelin measured in ng/ml 6 pm, end of the cycloergometer day
Secondary Blood cortisol Blood cortisol measured in ng/ml or nmol/l 6 am, beginning of the cycloergometer day
Secondary Blood cortisol Blood cortisol measured in ng/ml or nmol/l 6 pm, end of the cycloergometer day
Secondary Blood DHEAS Blood DHEAS measured in µg/ml 6 am, beginning of the cycloergometer day
Secondary Blood DHEAS Blood DHEAS measured in µg/ml 6 pm, end of the cycloergometer day
Secondary Blood leptin Blood leptin measured in ng/ml 6 am, beginning of the cycloergometer day
Secondary Blood leptin Blood leptin measured in ng/ml 6 pm, end of the cycloergometer day
Secondary Blood ghrelin Blood ghrelin measured in pg/ml 6 am, beginning of the cycloergometer day
Secondary Blood ghrelin Blood ghrelin measured in pg/ml 6 pm, end of the cycloergometer day
Secondary Blood BDNF Blood brain-derived neurotrophic factor (BDNF) measured in pg/ml 6 am, beginning of the cycloergometer day
Secondary Blood BDNF Blood brain-derived neurotrophic factor (BDNF) measured in pg/ml 6 pm, end of the cycloergometer day
Secondary Blood pro-inflammatory cytokines Blood pro-inflammatory cytokines measured in pg/ml 6 am, beginning of the cycloergometer day
Secondary Blood pro-inflammatory cytokines Blood pro-inflammatory cytokines measured in pg/ml 6 pm, end of the cycloergometer day
Secondary Blood NPY Blood vascular distribution of neuropeptide Y (NPY) measured in pg/ml 6 am, beginning of the cycloergometer day
Secondary Blood NPY Blood vascular distribution of neuropeptide Y (NPY) measured in pg/ml 6 pm, end of the cycloergometer day
See also
  Status Clinical Trial Phase
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Recruiting NCT04994340 - Physical Activity Observatory of Castilla-La Mancha
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05019482 - Intervention Program Among University Student to Promote Physical Activity and Reduce the Sedentary Time N/A
Not yet recruiting NCT05963893 - Promoting a Healthy Life Through Gender Equity
Completed NCT05059964 - Circuit Training and Aerobic Exercise Among Sedentary Elderly Population N/A
Completed NCT06063187 - Technology-based Fall Risk Assessments for Older Adults in Low-income Settings
Completed NCT04042610 - Office Worker Behavior and Health Study N/A
Recruiting NCT05961943 - RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients N/A
Completed NCT05013021 - Sprint Interval Training on the Endurance, Strength and Velocity Capacities of Healthy Sedentary Subjects N/A
Active, not recruiting NCT04569578 - Increasing Children's Physical Activity by Policy (CAP) N/A
Recruiting NCT04195165 - The Effect of Sitting and Moderate Exercise on Plasma Insulin and Glucose Responses to an Oral Glucose Tolerance Test N/A
Completed NCT04082624 - Workplace Wellness: Improving Your Experience at Work N/A
Completed NCT02544867 - Optimizing Sedentary Behavior Interventions to Affect Acute Physiological Changes N/A
Completed NCT06024434 - Effects of Specialized Strength Training Protocol On Functional Movement Status of Office Workers N/A
Withdrawn NCT05605028 - A Mental Health Intervention for a Community Program Called the PowerObesity N/A
Completed NCT04556695 - Exploration of Sedentary Behaviour Among General Practitioners: A Mixed Methods Study
Recruiting NCT05790837 - Workplace Intervention to Reduce Sitting Time: a Randomized Clinical Trial. N/A
Completed NCT06018974 - Digital Gaming Intervention for Older People in Long-term Care N/A
Recruiting NCT05534256 - Reducing Sedentary Time in Patients With Cardiovascular Disease N/A